Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the
Wen-Chien Cheng1,2,3, Chia-Ling Chang4,5, Chau-Chyun Sheu6,7
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Background:
Non-cystic fibrosis bronchiectasis (NCFB) is linked to an increased incidence of cardiovascular disease (CVD), but its impact on mortality is unclear. This study aimed to assess the effect of CVD on mortality and its relationship with clinical characteristics in NCFB patients.
Methods:
This multicentre retrospective study analysed baseline characteristics and outcomes of 2753 NCFB patients, including 648 with CVD. Univariate and multivariate analyses identified factors associated with CVD and mortality, comparing demographics, comorbidities and pulmonary function between patients with and without CVD.
Results:
Patients with CVD were significantly older (76.4 versus 68.8 years, p<0.001), had higher body mass index (BMI) (22.9 versus 21.5 kg·m-2, p<0.001) and more comorbidities. Age (hazard ratio (HR) 1.046, p<0.001), BMI (HR 1.089, p<0.001) and comorbidity score (HR 1.698, p<0.001) were independent risk factors for CVD. Mortality risk factors in NCFB patients included older age (HR 1.032, p=0.042), Pseudomonas aeruginosa infection (HR 3.353, p=0.002), emergency visits (HR 2.455, p<0.001), COPD (HR 2.563, p=0.005) and CVD (HR 2.146, p=0.015).
Conclusion:
CVD in NCFB is associated with severe clinical profiles and poor outcomes. Older age, higher BMI and comorbidity burden significantly correlate with CVD presence. CVD is an independent risk factor for mortality, highlighting the importance of early identification and management of cardiovascular comorbidities in patients with NCFB.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

